Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank58
3Y CAGR-8.0%
5Y CAGR-19.5%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-8.0%/yr
Quarterly compound
5Y CAGR
-19.5%/yr
Recent acceleration
Percentile
P58
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 8.47% |
| Q3 2025 | -4.29% |
| Q2 2025 | 11.87% |
| Q1 2025 | -2.66% |
| Q4 2024 | -2.48% |
| Q3 2024 | 7.85% |
| Q2 2024 | 4.99% |
| Q1 2024 | 5.58% |
| Q4 2023 | -3.03% |
| Q3 2023 | 5.69% |
| Q2 2023 | 23.48% |
| Q1 2023 | -17.27% |
| Q4 2022 | 10.89% |
| Q3 2022 | -3.14% |
| Q2 2022 | 14.86% |
| Q1 2022 | 4.91% |
| Q4 2021 | -16.17% |
| Q3 2021 | -6.58% |
| Q2 2021 | 10.93% |
| Q1 2021 | 14.66% |
| Q4 2020 | 25.07% |
| Q3 2020 | -7.39% |
| Q2 2020 | -21.40% |
| Q1 2020 | 66.46% |
| Q4 2019 | 102.51% |
| Q3 2019 | -48.28% |
| Q2 2019 | 26.68% |
| Q1 2019 | -57.04% |
| Q4 2018 | -3.35% |
| Q3 2018 | 12.23% |
| Q2 2018 | 23.31% |
| Q1 2018 | -4.50% |
| Q4 2017 | 12.15% |
| Q3 2017 | 9.12% |
| Q2 2017 | 12.64% |
| Q1 2017 | -37.82% |
| Q4 2016 | 0.00% |